Sepsis Foundation   Report issue

Foundation Phase 3
Founded: Jena Germany (2012)

Organization Overview

First Clinical Trial
2012
NCT00135473
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

German Competence Network Sepsis | Kompetenznetz Sepsis | SepNet - Critical Care Trials Group

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Sepsis (Phase 3)

Shock (Phase 3)

Shock, Septic (Phase 3)

Toxemia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 9